Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer

NCT00004144 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: bryostatin 1
DRUG: gemcitabine hydrochloride

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]